Entradas

El pasado miércoles 25 de Agosto se llevó a cabo la primera implantación del nuevo sistema de fijación PERLA® TL MIS en España como parte del lanzamiento limitado Global Spineart. El caso tratado fue una fractura instrumentada L2-L5 y realizado por el equipo del Dr. Gerd Bordon en el Hospital de Manises de Valencia.

El grado de satisfacción general en cuanto a la nueva instrumentación e implantes es excelente.!! El nuevo sistema permitirá tratar a pacientes con múltiples patologías degenerativas y fracturas traumáticas de forma segura a través de una técnica sencilla y reproducible y una instrumentación versátil.

PERLA® TL MIS está diseñado para proporcionar una solución fiable y eficiente en la cirugía mínimamente invasivo y es la extensión natural de PERLA® TL, la nueva plataforma torácico-lumbar Spineart posterior.

On August 16^th 2021, Dr. Moszko, MVZ Klinikum (Deggendorf, Germany) performed the first European PERLA® TL MIS surgery during which he did a 5 level fusion from Th10 to L3.

Dr Moszko declared that – “The intuitive and easy to use instrumentation of the PERLA® TL MIS system, coupled with its slim extended screws, are a real step forward in Spineart’s product portfolio”.

PERLA® TL MIS is designed to provide a reliable and efficient solution in Minimally Invasive Surgery and is the natural extension of PERLA® TL, the new Spineart Posterior Thoraco-lumbar platform.

Following the success of our last year event in Nanchang, Spineart is proud to have hosted a new Cervical Arthroplasty Expert Meeting in China, held in Beijing on the 24th of July 2021.

The meeting philosophy was “Why, When and How” to use our NMPA (National Medical Products Administration) approved arthroplasty device, BAGUERA® C. Rather than a lecture-oriented event, we offered an interactive experience between 42 spine experts, based on group clinical cases discussions and live surgery at the Peking University Third Hospital (PUTH).

We’d like to extend again our deep  gratitude to the Chairman, Speakers and the local organization team who greatly contributed to the success of this event.

Spineart UK is proud to announce that it is now officially approved on all three National Health Services (NHS) frameworks covering England, Scotland and Wales. The UK Team has celebrated this achievement coupled with the opening of their new commercial base, where an onsite training facilities for Healthcare Professionals, Surgeons and Staff has been opened.

We are looking forward to the future of Spineart UK!

Spineart is proud to announce the first surgery involving PERLA® TL MIS, the new MIS Thoraco-lumbar Fixation System.

On July 26^th 2021, Dr. Sharma, Spotsylvania Regional Medical Center (Virginia, USA), performed the first worldwide surgery involving 2-levels (L3-L5). Dr. Sharma declared that – “The PERLA® TL MIS system is unique in its ability to reduce the rod into the screw tulips. It also eliminates many unnecessary steps for insertion of pedicle screws in a MIS manner.”

PERLA® TL MIS is designed to provide a reliable and efficient solution in Minimally Invasive Surgery and is the natural extension of PERLA® TL, the new Spineart Posterior Thoraco-lumbar platform.

After a successful limited release period and already more than 1000 surgeries performed, SPINEART is proud to announce the official full launch of PERLA® TL, the new Posterior Thoraco-lumbar Fixation System.

Built on 15 years of successful experience with the ROMEO® system, patient’s safety oriented, with full implant system offered sterile and simplicity driven in its ancillaries conception, PERLA® TL is ready to go worldwide.

The system combines a set of simplified instrumentation with smart instrument design and a complete range of sterile-packed bar-coded implants, which include pedicle screws with the following features: Friction Tulip Head with Double Rod Diameter Compatibility and a Screw Shaft incorporating a Dual Core and Dual Threads design.

PERLA® TL is the first step of a brand new posterior thoraco-lumbar fixation platform. Further extensions will be announced.

For more information, visit our product page.